Filing Details

Accession Number:
0001209191-17-053335
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-19 17:28:41
Reporting Period:
2017-09-17
Accepted Time:
2017-09-19 17:28:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1368148 Athersys Inc / New ATHX Pharmaceutical Preparations (2834) 204864095
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1402609 Jr William Lehmann 3201 Carnegie Avenue
Cleveland OH 44115-2634
President And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-09-17 8,668 $2.22 527,380 No 4 F Direct
Common Stock Disposition 2017-09-19 15,000 $2.38 512,380 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
Footnotes
  1. Shares withheld from the quarterly vesting of annual restricted stock unit awards related to the minimum tax withholding obligation.
  2. Shares sold pursuant to a predefined Rule 10b5-1 trading plan for tax and planning purposes.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.35 to $2.42, inclusive, in accordance with a previously established Rule 10b5-1 predefined trading plan enacted for tax and planning purposes.
  4. Securities beneficially owned are comprised of: (1) 227,842 shares of common stock owned and (2) unvested restricted stock units aggregating 284,538 related to annual awards, which vest quarterly over a four-year period from grant date.